Last reviewed · How we verify

NCT04159064

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

Completed Last updated 13 November 2019
What this trial tests

trial testing Thromboelastometry, Impedance Aggregometry in Extracorporeal Circulation; Complications in 57 participants. Completed in 30 April 2019.

Timeline
1 December 2018
Primary endpoint
30 April 2019
30 April 2019

Quick facts

Lead sponsorAHEPA University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment57
Start date1 December 2018
Primary completion30 April 2019
Estimated completion30 April 2019
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

AHEPA University Hospital

Who can join

Adults 18 to 79, any sex, with Extracorporeal Circulation; Complications or Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study includes patients undergoing elective cardiac surgery on MiECC. Coagulation status is assessed with ROTEM (TEM International GmbH, Munich, Germany) and Platelet function with impedance aggregometry using the ROTEM-Platelet (TEM International GmbH, Munich, Germany).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Extracorporeal Circulation; Complications

Currently open trials in the same condition.

Other AHEPA University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04159064.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing